Processa Pharmaceuticals Inc (PCSA) Stock Analysis

Processa Pharmaceuticals Inc (PCSA) is a publicly traded company in the HEALTHCARE sector. It trades at $2.92, carries a market capitalization of $6.96M. This page summarizes the public market data, fundamentals, and frequently asked questions for PCSA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Processa Pharmaceuticals Inc currently has a Bullish sentiment score of 0.34.

About Processa Pharmaceuticals Inc

Processa Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Hanover, Maryland, focused on developing innovative therapies to address unmet medical needs. The company specializes in advancing its proprietary drug candidates through clinical trials, specifically targeting diseases with limited or ineffective treatment options. With a commitment to tackling significant health challenges, Processa aims to enhance patient outcomes and quality of life. As it navigates its ...

GNG Research Analysis

GNG Research scores Processa Pharmaceuticals Inc (PCSA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PCSA.

Frequently Asked Questions

Does PCSA pay dividends?

Processa Pharmaceuticals Inc (PCSA) does not currently pay a regular dividend.

What is PCSA's market cap?

Processa Pharmaceuticals Inc (PCSA) has a market capitalization of $6.96M with a current stock price of $2.92.